DOPAMINERGIC NEURONAL SURVIVAL-PROMOTING FACTORS AND USES THEREOF

Details for Australian Patent Application No. 2002240760 (hide)

Owner PRESCIENT NEUROPHARMA INC.

Inventors COMMISSIONG, John, W.; RAIBEKAS, Andrei, A.

Pub. Number AU-A-2002240760

PCT Pub. Number WO2002/074956

Priority 60/277,516 20.03.01 US

Filing date 20 March 2002

Wipo publication date 3 October 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 015/867 Mutation or genetic engineering - Retroviral vectors

C07K 014/47 Peptides having more than 20 amino acids

A61K 038/17 Medicinal preparations containing peptides - from animals

C12N 005/06 Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 015/861 Mutation or genetic engineering - Adenoviral vectors

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002240760

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002240761-System and process for the treatment of gaseous emissions

2002240759-GOLF PRACTICE APPARATUS